Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial

Contraception

Volumn 80, Issue 6, 2009, Pages 504-511

  Teichmann, Alexander ^a   Apter, Dan ^b   Emerich, Janusz ^c   Greven, Klaus ^d   Klasa Mazurkiewicz, Dagmara ^c   Melis, Giambi B ^e   Spaczynski, Marek ^f   Grubb, Gary S ^g   Constantine, Ginger D ^g   Spielmann, Daniele ^h  

^a KLINIKUM ASCHAFFENBURG   (Germany)

^b Vaestoliitto   (Finland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d University of Cagliari ^*

^e University of Cagliari   (Poland)

^f POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^g PFIZER INC   (United States)

^h Wyeth Pharmaceuticals   (United States)

Author keywords

Continuous oral contraceptive; Efficacy; Levonorgestrel; Menses suppression; Safety

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL;

ADULT; AMENORRHEA; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MENORRHAGIA; METRORRHAGIA; MORBIDITY; NORMAL HUMAN; ORAL CONTRACEPTION; SAFETY; SPOTTING; VAGINA BLEEDING; WITHDRAWAL BLEEDING;

EID: 70350776670     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.05.128     Document Type: Article

References (21)

1. Loudon N.B., Foxwell M., Potts D.M., Guild A.L., and Short R.V. Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regiment. Br Med J 2 (1977) 487-490
2. Kovacs G.T., Rusden J., and Evans A. A trimonthly regimen for oral contraceptives. Br J Fam Plann 19 (1994) 274-275
3. Anderson F.D., Hait H., and The Seaonale-301 Study Group. A multicenter, randomized study of an extended cycle of oral contraceptive. Contraception 68 (2003) 89-96
4. Andrist L.C., Arias R.D., Nucatola D., et al. Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception 70 (2004) 359-363
5. Wiegratz I., Hommel H.H., Zimmermann T., and Kuhl H. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception 69 (2004) 37-42
6. den Tonkelaar I., and Oddens B.J. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. Contraception 59 (1999) 357-362
7. Ferrero S., Abbamonte L.H., Giordano M., et al. What is the desired menstrual frequency of women without menstruation-related symptoms?. Contraception 73 (2006) 537-541
8. Glasier A.F., Smith K.B., van der Spuy Z.M., et al. Amenorrhea associated with contraception - an international study on acceptability. Contraception 67 (2003) 1-8
9. Archer DF, Kovalevsky G, Ballagh S, Grubb GS. Effect on ovarian activity of a novel levonorgestrel/ethinyl estradiol oral contraceptive regimen. Fertil Steril [Epub ahead of print, May 4, 2009].
10. Belsey E.M., Machin D., and d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and research training in human reproduction. Contraception 34 (1986) 253-260
11. U.S. Food and Drug Administration. Depot medroxyprogesterone, summary basis of approval, medical review. October 27, 1992.
12. Jain J., Jakimiuk A.J., Bode F.R., Ross D., and Kaunitz A.M. Contraceptive efficacy and safety of DMPA-SC. Contraception 70 (2004) 269-275
13. Archer D.F., Jensen J.T., Johnson J.V., Borisute H., Grubb G.S., and Constantine G.D. Evaluation of a continuous regiment of levonorgestrel/ethinyl estradiol: phase 3 study results. Contraception 74 (2006) 439-445
14. Birtch R.L., Olatunbosun O.A., and Pierson R.A. Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use. Contraception 73 (2006) 235-243
15. Legro R.S., Pauli J.G., Kunselman A.R., et al. Effects of continuous versus cyclical oral contraception: a randomized controlled trial. J Clin Endocrinol Metab 93 (2008) 420-429
16. Schlaff W.D., Lynch A.M., Hughes H.D., Cedars M.I., and Smith D.L. Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression. Am J Obstet Gynecol 190 (2004) 943-951
17. Archer D.F., Maheux R., DelConte A., O'Brien F.B., and North American Levonorgestrel Study Group (NALSG). Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse). Am J Obstet Gynecol 181 (1999) S39-S44
18. Guilbert E., Boroditsky R., Black A., et al. Canadian Consensus Guideline on Continuous and Extended Hormonal Contraception, 2007. J Obstet Gynaecol Can 29 (2007) S1-S32
19. Barnhart K., Mirkin S., Grubb G., and Constantine G. Return to fertility after cessation of a continuous oral contraceptive. Fertil Steril 91 (2009) 1654-1656
20. Johnson J.V., Grubb G.S., and Constantine G.D. Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 μg/ethinyl estradiol 20 μg. Contraception 75 (2007) 23-26
21. Miller L., and Hughes J.P. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. Obstet Gynecol 101 (2003) 653-661